|
The Human Basal Forebrain. Part I. an Overview |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 | (1) |
|
|
|
1 | (5) |
|
|
|
2 | (1) |
|
Olfactory peduncle and olfactory tract |
|
|
2 | (1) |
|
Olfactory tubercle and anterior perforated space |
|
|
3 | (3) |
|
|
|
6 | (1) |
|
Overview of basal forebrain structures |
|
|
6 | (5) |
|
Area diagonalis (diagonal band of Broca) and basal nucleus of Meynert |
|
|
6 | (1) |
|
Olfactory bulb projection areas |
|
|
7 | (1) |
|
|
|
7 | (1) |
|
Dorsal striatum and dorsal pallidum |
|
|
8 | (1) |
|
Ventral striatum and ventral pallidum |
|
|
9 | (1) |
|
Striatum in the temporal lobe |
|
|
9 | (1) |
|
|
|
10 | (1) |
|
|
|
11 | (1) |
|
|
|
11 | (1) |
|
Coronal sections through the basal forebrain |
|
|
11 | (1) |
|
|
|
11 | (1) |
|
|
|
12 | (1) |
|
|
|
13 | (44) |
|
Mini-atlas of coronal sections through the basal forebrain |
|
|
15 | (42) |
|
The Human Basal Forebrain. Part II. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
57 | (7) |
|
|
|
60 | (1) |
|
`Basalkerncomplex' of Brockhaus |
|
|
60 | (3) |
|
|
|
63 | (1) |
|
Ventral striatopallidal system |
|
|
64 | (29) |
|
|
|
65 | (2) |
|
The heterogeneity of ventral striatum |
|
|
67 | (15) |
|
|
|
82 | (7) |
|
Core and shell subdivisions of the accumbens |
|
|
89 | (1) |
|
|
|
90 | (3) |
|
|
|
93 | (53) |
|
Bed nucleus of stria terminalis |
|
|
98 | (1) |
|
Lateral division of bed nucleus |
|
|
98 | (7) |
|
Medial division of bed nucleus |
|
|
105 | (1) |
|
Sublenticular components of extended amygdala |
|
|
105 | (2) |
|
Central division of the sublenticular extended amygdala |
|
|
107 | (7) |
|
Medial division of sublenticular extended amygdala |
|
|
114 | (1) |
|
|
|
114 | (2) |
|
Central amygdaloid nucleus |
|
|
116 | (6) |
|
Medial amygdaloid nucleus |
|
|
122 | (2) |
|
Stria terminalis components of the extended amygdala |
|
|
124 | (1) |
|
Supracapsular part of the stria terminalis |
|
|
125 | (13) |
|
Subcapsular part of the stria terminalis |
|
|
138 | (6) |
|
Transition areas between extended amygdala and the striatopallidal system |
|
|
144 | (2) |
|
|
|
146 | (10) |
|
Primary non-amygdaloid olfactory bulb projection areas |
|
|
147 | (1) |
|
Anterior olfactory nucleus (retrobulbar area) |
|
|
147 | (1) |
|
Primary olfactory cortex (`piriform cortex') |
|
|
148 | (3) |
|
Insular and temporopolar periallocortical areas |
|
|
151 | (1) |
|
Ventral striatum vs olfactory tubercle |
|
|
152 | (1) |
|
Olfactory association areas in the orbitofrontal cortex |
|
|
153 | (1) |
|
|
|
154 | (1) |
|
Olfactory entorhinal field |
|
|
155 | (1) |
|
Superficial amygdala and the laterobasal complex |
|
|
156 | (31) |
|
General structure of the amygdala |
|
|
156 | (5) |
|
|
|
161 | (1) |
|
Is the superficial amygdala a cortical or subcortical structure? |
|
|
161 | (1) |
|
Superficial amygdala: a plethora of terms |
|
|
162 | (7) |
|
Review of superficial amygdaloid structures |
|
|
169 | (7) |
|
Laterobasal amygdaloid complex |
|
|
176 | (2) |
|
Lateral amygdaloid nucleus |
|
|
178 | (3) |
|
Basolateral amygdaloid nucleus |
|
|
181 | (2) |
|
The basomedial amygdaloid nucleus |
|
|
183 | (2) |
|
The paralaminar amygdaloid nucleus |
|
|
185 | (1) |
|
Intramedullary gray substance and intercalated (interface) islands |
|
|
186 | (1) |
|
|
|
187 | (1) |
|
Appendix: comparison of nomenclature for the human amygdala |
|
|
187 | (19) |
|
|
|
187 | (1) |
|
|
|
188 | (18) |
|
|
|
206 | (1) |
|
|
|
206 | (3) |
|
|
|
209 | (18) |
|
Chemical Architecture of the Basal Ganglia |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
227 | (1) |
|
Systems approach to the basal ganglia |
|
|
228 | (19) |
|
The basal ganglia proper and their allied nuclei |
|
|
228 | (3) |
|
The connections of the basal ganglia: An overview |
|
|
231 | (1) |
|
|
|
232 | (1) |
|
|
|
232 | (3) |
|
The striosomal output pathway |
|
|
235 | (1) |
|
General modular architecture of the striatum: striosomes and matrisomes |
|
|
235 | (2) |
|
Loop systems of the basal ganglia |
|
|
237 | (3) |
|
Transmitter-related compounds associated with basal ganglia pathways |
|
|
240 | (5) |
|
Neuropeptides in basal ganglia pathways |
|
|
245 | (2) |
|
Neurotransmitter-related compounds in striatal interneurons |
|
|
247 | (1) |
|
Functional concepts about the basal ganglia |
|
|
247 | (10) |
|
|
|
247 | (1) |
|
|
|
248 | (1) |
|
|
|
249 | (3) |
|
|
|
252 | (3) |
|
|
|
255 | (1) |
|
Neuropsychiatric disorders |
|
|
256 | (1) |
|
Chemically specified subsystems: receptor systems in the basal ganglia |
|
|
257 | (10) |
|
Receptors associated with basal ganglia afferents |
|
|
258 | (1) |
|
|
|
258 | (3) |
|
|
|
261 | (1) |
|
|
|
262 | (1) |
|
|
|
263 | (1) |
|
|
|
263 | (1) |
|
Receptors associated with intrinsic basal ganglia pathways |
|
|
263 | (1) |
|
|
|
263 | (2) |
|
|
|
265 | (1) |
|
|
|
265 | (1) |
|
|
|
265 | (1) |
|
|
|
266 | (1) |
|
|
|
266 | (1) |
|
|
|
267 | (1) |
|
|
|
267 | (3) |
|
Functional considerations: The involvement of basal ganglia dysfunction in the production of disordered movement |
|
|
267 | (3) |
|
|
|
270 | (1) |
|
|
|
270 | (15) |
|
Chemical Neuroanatomy of the Hippocampal Formation and the Perirhinal and Parahippocampal Cortices |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
285 | (8) |
|
Why the hippocampal formation? |
|
|
286 | (1) |
|
Why include the perirhinal and parahippocampal cortices? |
|
|
286 | (2) |
|
Organization of the chapter |
|
|
288 | (5) |
|
Overview of the components of the medial temporal lobe |
|
|
293 | (4) |
|
Cytoarchitectonic organization of the hippocampal formation |
|
|
297 | (7) |
|
Regional and cytoarchitectonic features of the perirhinal and parahippocampal cortices |
|
|
304 | (2) |
|
An overview of the connectivity of the hippocampal formation |
|
|
306 | (31) |
|
Intrinsic connections of the hippocampal formation |
|
|
306 | (30) |
|
Connections between the perirhinal and parahippocampal cortices and the hippocampal formation |
|
|
336 | (1) |
|
Other extrinsic connections of the hippocampal formation |
|
|
336 | (1) |
|
|
|
337 | (16) |
|
|
|
337 | (1) |
|
|
|
337 | (1) |
|
|
|
337 | (1) |
|
|
|
337 | (1) |
|
|
|
338 | (1) |
|
Metabotropic glutamate receptors |
|
|
338 | (1) |
|
|
|
339 | (1) |
|
|
|
339 | (1) |
|
Cholinergic fiber systems |
|
|
339 | (1) |
|
|
|
339 | (1) |
|
|
|
340 | (1) |
|
|
|
340 | (1) |
|
Cholinergic receptor systems |
|
|
341 | (1) |
|
|
|
341 | (1) |
|
GABAergic fiber innervation |
|
|
341 | (1) |
|
|
|
342 | (1) |
|
|
|
343 | (1) |
|
|
|
343 | (1) |
|
|
|
343 | (1) |
|
|
|
344 | (1) |
|
|
|
344 | (1) |
|
|
|
344 | (1) |
|
|
|
345 | (1) |
|
|
|
345 | (1) |
|
|
|
346 | (1) |
|
Vasoactive intestinal peptide |
|
|
346 | (1) |
|
|
|
346 | (1) |
|
|
|
346 | (1) |
|
|
|
347 | (1) |
|
Opioid peptides (dynorphin, enkephalin) |
|
|
347 | (1) |
|
|
|
347 | (1) |
|
|
|
348 | (1) |
|
|
|
348 | (2) |
|
|
|
350 | (1) |
|
|
|
350 | (1) |
|
|
|
351 | (1) |
|
|
|
351 | (1) |
|
|
|
351 | (1) |
|
Nitric oxide synthase and NADPH-diaphorase |
|
|
352 | (1) |
|
|
|
352 | (1) |
|
|
|
352 | (1) |
|
Ciliary neurotrophic factor |
|
|
353 | (1) |
|
Brain-derived neurotrophic factor |
|
|
353 | (1) |
|
|
|
353 | (13) |
|
|
|
353 | (1) |
|
|
|
353 | (1) |
|
|
|
353 | (1) |
|
|
|
354 | (1) |
|
Metabotropic glutamate receptors |
|
|
354 | (1) |
|
|
|
354 | (1) |
|
|
|
355 | (1) |
|
Cholinergic fiber systems |
|
|
355 | (1) |
|
|
|
356 | (1) |
|
|
|
356 | (1) |
|
|
|
356 | (1) |
|
|
|
357 | (2) |
|
|
|
359 | (1) |
|
|
|
359 | (1) |
|
|
|
359 | (1) |
|
|
|
359 | (1) |
|
|
|
360 | (1) |
|
|
|
360 | (1) |
|
|
|
360 | (1) |
|
|
|
360 | (1) |
|
|
|
361 | (1) |
|
|
|
361 | (1) |
|
|
|
361 | (1) |
|
|
|
362 | (1) |
|
|
|
362 | (1) |
|
|
|
362 | (1) |
|
|
|
362 | (1) |
|
Distribution of parvalbumin-positive fibers |
|
|
362 | (1) |
|
Distribution of parvalbumin-positive cell bodies |
|
|
363 | (1) |
|
|
|
364 | (1) |
|
|
|
365 | (1) |
|
|
|
365 | (1) |
|
|
|
365 | (1) |
|
|
|
365 | (1) |
|
Nitric oxide synthase and NADPH-diaphorase |
|
|
366 | (1) |
|
|
|
366 | (1) |
|
|
|
366 | (1) |
|
|
|
366 | (1) |
|
Ciliary neurotrophic factor |
|
|
366 | (1) |
|
Brain-derived neurotrophic factor |
|
|
366 | (1) |
|
|
|
366 | (7) |
|
|
|
366 | (1) |
|
|
|
366 | (1) |
|
|
|
367 | (1) |
|
|
|
367 | (1) |
|
Metabotropic glutamate receptors |
|
|
367 | (1) |
|
|
|
367 | (1) |
|
|
|
367 | (1) |
|
Cholinergic fiber systems |
|
|
367 | (1) |
|
|
|
368 | (1) |
|
|
|
368 | (1) |
|
|
|
368 | (1) |
|
|
|
368 | (1) |
|
|
|
368 | (1) |
|
|
|
369 | (1) |
|
|
|
369 | (1) |
|
|
|
369 | (1) |
|
|
|
369 | (1) |
|
|
|
369 | (1) |
|
|
|
369 | (1) |
|
|
|
369 | (1) |
|
|
|
369 | (1) |
|
|
|
370 | (1) |
|
|
|
370 | (1) |
|
|
|
370 | (1) |
|
|
|
370 | (1) |
|
|
|
370 | (1) |
|
|
|
370 | (1) |
|
Distribution of parvalbumin-positive fibers |
|
|
370 | (1) |
|
Distribution of parvalbumin-positive cells |
|
|
371 | (1) |
|
|
|
371 | (1) |
|
|
|
371 | (1) |
|
|
|
372 | (1) |
|
|
|
372 | (1) |
|
|
|
372 | (1) |
|
Nitric oxide synthase and NADPH-diaphorase |
|
|
372 | (1) |
|
|
|
372 | (1) |
|
|
|
372 | (1) |
|
Ciliary neurotrophic factor |
|
|
372 | (1) |
|
Brain-derived neurotrophic factor |
|
|
372 | (1) |
|
Presubiculum and parasubiculum |
|
|
373 | (5) |
|
|
|
373 | (1) |
|
|
|
373 | (1) |
|
|
|
373 | (1) |
|
Cholinergic fiber systems |
|
|
373 | (1) |
|
|
|
373 | (1) |
|
|
|
373 | (1) |
|
|
|
374 | (1) |
|
|
|
374 | (1) |
|
|
|
374 | (1) |
|
|
|
374 | (1) |
|
|
|
375 | (1) |
|
|
|
375 | (1) |
|
|
|
375 | (1) |
|
|
|
375 | (1) |
|
|
|
375 | (1) |
|
|
|
375 | (1) |
|
|
|
375 | (1) |
|
|
|
375 | (1) |
|
|
|
375 | (1) |
|
|
|
376 | (1) |
|
|
|
376 | (1) |
|
|
|
376 | (1) |
|
|
|
376 | (1) |
|
|
|
376 | (1) |
|
Parvalbumin in the presubiculum |
|
|
376 | (1) |
|
Distribution of parvalbumin-immunoreactive fibers |
|
|
376 | (1) |
|
Distribution of parvalbumin-immunoreactive cells |
|
|
376 | (1) |
|
Parvalbumin in the parasubiculum |
|
|
377 | (1) |
|
Distribution of parvalbumin-immunoreactive fibers |
|
|
377 | (1) |
|
Distribution of parvalbumin-immunoreactive cells |
|
|
377 | (1) |
|
|
|
377 | (1) |
|
|
|
377 | (1) |
|
|
|
378 | (1) |
|
|
|
378 | (1) |
|
|
|
378 | (1) |
|
Nitric oxide synthase and NADPH-diaphorase |
|
|
378 | (1) |
|
|
|
378 | (1) |
|
|
|
378 | (10) |
|
|
|
378 | (1) |
|
|
|
378 | (1) |
|
|
|
379 | (1) |
|
Cholinergic fiber systems |
|
|
379 | (1) |
|
|
|
380 | (1) |
|
|
|
380 | (1) |
|
|
|
380 | (1) |
|
|
|
381 | (1) |
|
|
|
381 | (1) |
|
|
|
381 | (1) |
|
|
|
382 | (1) |
|
|
|
382 | (1) |
|
|
|
382 | (1) |
|
|
|
383 | (1) |
|
|
|
383 | (1) |
|
|
|
383 | (1) |
|
|
|
384 | (1) |
|
|
|
384 | (1) |
|
|
|
384 | (1) |
|
|
|
385 | (1) |
|
|
|
385 | (1) |
|
|
|
385 | (1) |
|
|
|
385 | (1) |
|
|
|
385 | (1) |
|
Distribution of parvalbumin-immunoreactive fibers |
|
|
385 | (1) |
|
Distribution of parvalbumin-immunoreactive cells |
|
|
386 | (1) |
|
|
|
386 | (1) |
|
|
|
387 | (1) |
|
|
|
387 | (1) |
|
|
|
387 | (1) |
|
|
|
387 | (1) |
|
Nitric oxide synthase and NADPH-diaphorase |
|
|
387 | (1) |
|
|
|
388 | (1) |
|
|
|
388 | (1) |
|
Ciliary neurotrophic factor |
|
|
388 | (1) |
|
Brain-derived neurotrophic factor |
|
|
388 | (1) |
|
|
|
388 | (2) |
|
|
|
388 | (1) |
|
|
|
388 | (1) |
|
|
|
388 | (1) |
|
|
|
388 | (1) |
|
|
|
388 | (1) |
|
|
|
389 | (1) |
|
|
|
389 | (1) |
|
|
|
389 | (1) |
|
|
|
389 | (1) |
|
|
|
389 | (1) |
|
|
|
389 | (1) |
|
|
|
389 | (1) |
|
|
|
389 | (1) |
|
|
|
390 | (1) |
|
Nitric oxide synthase and NADPH-diaphorase |
|
|
390 | (1) |
|
|
|
390 | (1) |
|
|
|
390 | (1) |
|
|
|
390 | (1) |
|
Glutamate system/cholinergic system/GABAergic system/monoamines |
|
|
390 | (1) |
|
|
|
390 | (1) |
|
|
|
390 | (1) |
|
|
|
390 | (1) |
|
|
|
390 | (1) |
|
|
|
391 | (1) |
|
Nitric oxide synthase and NADPH-diaphorase |
|
|
391 | (1) |
|
|
|
391 | (1) |
|
|
|
391 | (1) |
|
|
|
392 | (1) |
|
|
|
393 | (10) |
|
The Primate Mesocortical Dopamine System |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
403 | (1) |
|
Primate specialization in the brainstem origin and organization of the mesocortical dopamine system |
|
|
403 | (3) |
|
Qualitative organization of the dopamine innervation of cerebral cortex |
|
|
406 | (2) |
|
Quantitative analysis of dopamine contacts on pyramidal and non-pyramidal neurons |
|
|
408 | (1) |
|
Electronmicroscopic evidence of dopamine synaptic triads and D1 receptor localization in spines |
|
|
409 | (2) |
|
Dopamine innervation of the microvasculature |
|
|
411 | (1) |
|
Dopamine D1 and D2 family of receptors in the cerebral cortex |
|
|
412 | (4) |
|
Localization of the D1 family of DA receptors in prefrontal cortex |
|
|
412 | (1) |
|
Localization of the D2 family of DA receptors in prefrontal cortex |
|
|
413 | (3) |
|
Role of dopamine receptors in cortical function |
|
|
416 | (4) |
|
Regulation of cortical dopamine receptors as targets of antipsychotic drugs |
|
|
420 | (2) |
|
Effect of antipsychotic medications on the D2 receptors in the primate cerebral cortex |
|
|
420 | (2) |
|
Summary and future directions |
|
|
422 | (1) |
|
|
|
423 | (6) |
| Subject Index |
|
429 | |